Deal score
Domain rating
Backlinks
Organic traffic
Current bid
Auction ends
DR-59 authority for $1,575 · 1,841 referring domains · real content since 2014
Auction ended
$432
below valuation
12
competing bids
Auction ended
remaining
PearTherapeutics.com is a premium health-tech domain with a substantial archive history as the corporate site of Pear Therapeutics. Captures include products, science, about-us, and investor subdomains, showing a real digital therapeutics company. The anchor profile is natural and includes high-authority references to FDA approvals and prescription digital therapeutics. The name is highly brandable for a healthcare or medical software venture, but its known trademark history creates legal risk. It is one of the strongest assets in this set from a history and authority perspective.
SEO value
The domain has a deep, high-quality archive and a natural anchor profile tied to digital therapeutics and FDA-related coverage. It carries strong SEO and brand value for health-tech, though trademark history must be considered.
No traffic history recorded.
Wayback captures by year
No keywords recorded.
Backlink quality
Recorded backlink quality is 70/100.
Marketplace content flag
GoDaddy content classification is not available.
Archive continuity
Largest recorded archive gap is 175 days.
Actual links pointing to this domain
| Source page | DR | Anchor and target | Type | Status | |
|---|---|---|---|---|---|
en Empatica en.wikipedia.org | 97 | "Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Sensor-Based Technologies" .Pear Therapeutics.peartherapeutics.com/pear-therapeutics-expands-platform-with-digital-biomarkers-machine-learning-algorithms-and-sensor-based-technologies/ | Raw HTML | Indexed | |
wi 5 Sleep Apps and Gadgets to Help With Insomnia | WIRED wired.com | 92 | For digital sleep coaching, he suggests Somryst and Sleepio , (the former is approved by the Foodpeartherapeutics.com/products/somryst/ | Rendered | Indexed | |
bu Pharma Giants Like Novartis, Sanofi Turn to Tech to Bolster Drugs - Business Insider businessinsider.com | 92 | substance use disorder, approved by the FDA in 2017, followed in December by its second approval , this time for a digital therapeutic for opioid usepeartherapeutics.com/sandoz-inc-and-pear-therapeutics-obtain-fda-clearance-for-reset-o-to-treat-opioid-use-disorder/ | Rendered | Indexed | |
lo Research Update on Sleep - Stanford Center on Longevity longevity.stanford.edu | 92 | as SleepRate , which features content designed by Stanford researchers, Somryst , which was recently approved by the FDA, and Sleepiopeartherapeutics.com/products/somryst/ | Rendered | Indexed | |
cr Pear Therapeutics - Crunchbase Company Profile & Funding crunchbase.com | 91 | peartherapeutics.compeartherapeutics.com | Rendered | Indexed |
Websites currently linking to this domain
Showing a stored sample of 3 of 1,841 referring domains reported by Ahrefs.
Referring Domain | ||
|---|---|---|
| cambridge.org | 100 | 1 |
| indeed.com | 100 | 1 |
| nih.gov | 100 | 5 |
3 entries
Diversified organic demand
No traffic history recorded.
Keyword | ||
|---|---|---|
| No keywords match these filters. | ||
No data recorded.
No data recorded.
Archive workspace
Archive verdict
Captures run without a material break across the observed span.
First real content
first 200 HTML calc
Last real content
not the last capture
Coverage
of 147 span months
Largest gap
Monthly · UTC · zero months shown
Era classification is inf from the capture mix.
Peak cadence
714/mo calc
Content months
81 calc
Material gaps
2 calc
Largest gap · 175 dayscalc
Cadence 0/mo before → 4/mo after. calc
No captures since calc
Sep 2026 — 53 days and counting.
Not counted as a gap: nothing bounds it on the far side. Absence of captures is not proof the site is down.
Other material gaps
Explore historical captures of the domain
Showing 1–20 of 50 captures